{"id":657,"date":"2013-12-31T10:24:17","date_gmt":"2013-12-31T18:24:17","guid":{"rendered":"https:\/\/phcprimarycare.org\/?p=657"},"modified":"2014-02-19T12:06:42","modified_gmt":"2014-02-19T20:06:42","slug":"the-art-of-warmedicine","status":"publish","type":"post","link":"https:\/\/phcprimarycare.org\/?p=657","title":{"rendered":"The Art of War\/Medicine"},"content":{"rendered":"<p>Recently updated guidelines for treatment of high cholesterol levels have just been released by the American College of Cardiology \u2013 American Heart Association Task Force on Practice Guidelines. They\u00a0represent a change <!--more-->from the prior recommendations which targeted specific lipid goals. Now, the new guidelines\u00a0emphasize the intensity of statin therapy.<sup>1<\/sup><\/p>\n<p>High-intensity statin therapy is now recommended for three groups, those with:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (1)\u00a0clinically evident CVD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (2)\u00a0primary LDL-C levels of at least 190mg\/dl\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (3)\u00a0type 1 or type 2 DM who are ages 40-75, have LDL levels of 70 mg\/dl or higher, and who have a 10-year risk of ASCVD of 7.5% or higher <sup>2,3<\/sup><\/p>\n<p>Those in the third group can be treated with high- or moderate-intensity statins. Those with diabetes types 1 or 2, ages 40-75, who have an LDL of 70-189 mg\/dl and a 10-year ASCVD risk of &lt; 7.5% can be treated with moderate-intensity statin therapy.\u00a0<\/p>\n<p>Moderate-intensity statin therapy is recommended for those who cannot tolerate otherwise-indicated high-intensity treatment.<\/p>\n<p>High-intensity statin treatment includes formulary agent atorvastatin 40-80 mg and non-formulary rosuvastatin 20-40 mg. Moderate-intensity treatment includes formulary agents atorvastatin 10-20 mg, simvastatin 20-40 mg, pravastatin 40-80 mg, lovastatin 40 mg, and fluvastatin 40 mg bid. Non-formulary agents in the moderate-intensity category include rosuvastatin\u00a05-10 mg, pitavastatin 2-4 mg, and fluvastatin ER 80 mg.<\/p>\n<p>The new guidelines reduce the need for treatment of some groups; eliminate LDL assessments in patients on appropriate statin treatment; avoid non-statin treatments if statins are tolerated; reduce statin treatment in those older than 75 years of age; diminish the use of surrogate markers like CRP; and use a new, more inclusive risk calculator. Non-statin lipid-reducing treatment should not be given in place of appropriate-intensity statin treatment. However, it can be given to those at high risk (those with established ASCVD, LDL <span style=\"text-decoration: underline;\">&gt;<\/span> 190 mg\/dl, or with diabetes) who cannot tolerate a less-than-recommended-intensity statin or who are statin intolerant, taking into consideration potential adverse drug effects.<\/p>\n<p>This move to high-intensity statin treatment has immediate application in my clinical practice. This past week I saw a relatively new patient in my HIV consultation clinic. This patient is a veteran of the HIV wars of the 80s and 90s but made it through with good adherence. Unfortunately, this patient, a non-smoker, had also had a coronary artery stent placed for CAD manifest by angina. He was on atorvastatin at 20 mg\/day and a fibrate for elevated triglycerides, along with ASA.<\/p>\n<p>The cascade of decisions began to fall into place.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (1)\u00a0Per the new guidelines, he needs a higher dose of atorvastatin.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (2)\u00a0This may cause trouble with the fibrate he is also taking.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (3)\u00a0Maybe he does not need the fibrate, depending on his triglyceride level?\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (4)\u00a0Could he use omega fatty acids instead?\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (5)\u00a0The HIV medicine he is now on, efavirenz, raises LDL and, even more so, triglycerides.(6)\u00a0So, should I change his HIV meds? To what?\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a. Could he harbor HIV resistance that would cause failure of a new regimen and what would be the consequence \u2013 back-up regimens?\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 b. His history of control with the current HIV regimen argues against significant resistance to a possible change in regimens. In particular, it is highly unlikely he has resistance to integrase strand transfer inhibitors.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 c. Once daily, relatively simple regimens that don\u2019t raise lipids include:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 i.\u00a0Dolutegravir (an integrase inhibitor) plus either a tenofovir\/emtricitabine combination pill or an abacavir\/lamivudine combination pill \u2013 this is a two-pill once-a-day choice.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ii.\u00a0The 3-in-1 pill tenofovir\/emtricitabine\/rilpivirine, a change that swaps one non-nucleoside reverse transcriptase (efavirenz) for another (rilpivirine), but this combination is not approved for HIV medication-experienced patients.\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 iii. The 4-in-1pill tenofovir\/emtricitabine\/cobicistat\/elvitegravir; this regimen is also integrase inhibitor based but with a CYP3A inhibitor (cobicistat) that can have other drug interactions.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 iv.\u00a0Numerous other regimens are possible \u2013 but they involve more pills and are more complex.<\/p>\n<p>Well, I am fully confident we can move this patient to high-intensity statin treatment while maintaining control of HIV. Ideally this will be done while minimizing side effects and drug interactions and simultaneously helping maintain adherence in this veteran of HIV history.<\/p>\n<p>Marshall Kubota, MD<\/p>\n<p><i>1.\u00a0<\/i><em>J Am Coll Cardiol<\/em>. 2013;():. doi:10.1016\/j.jacc.2013.11.002\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <i>2.\u00a0<\/i><a href=\"http:\/\/my.americanheart.org\/cvriskcalculator\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0%203\">http:\/\/my.americanheart.org\/cvriskcalculator<i>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 3<\/i><\/a>.\u00a0<a href=\"http:\/\/my.americanheart.org\/cvriskcalculator\">http:\/\/my.americanheart.org\/cvriskcalculator<\/a> or at <a href=\"http:\/\/www.cardiosource.org\/science-and-quality\/practice-guidelines-and-quality-standards\/2013-prevention-guideline-tools.aspx\">http:\/\/www.cardiosource.org\/science-and-quality\/practice-guidelines-and-quality-standards\/2013-prevention-guideline-tools.aspx<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently updated guidelines for treatment of high cholesterol levels have just been released by the American College of Cardiology \u2013 American Heart Association Task Force on Practice Guidelines. They\u00a0represent a change<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[15,13],"tags":[],"class_list":["post-657","post","type-post","status-publish","format-standard","hentry","category-medical-practice","category-prevention"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Art of War\/Medicine - PHC Primary Care Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/phcprimarycare.org\/?p=657\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Art of War\/Medicine - PHC Primary Care Blog\" \/>\n<meta property=\"og:description\" content=\"Recently updated guidelines for treatment of high cholesterol levels have just been released by the American College of Cardiology \u2013 American Heart Association Task Force on Practice Guidelines. They\u00a0represent a change\" \/>\n<meta property=\"og:url\" content=\"https:\/\/phcprimarycare.org\/?p=657\" \/>\n<meta property=\"og:site_name\" content=\"PHC Primary Care Blog\" \/>\n<meta property=\"article:published_time\" content=\"2013-12-31T18:24:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-02-19T20:06:42+00:00\" \/>\n<meta name=\"author\" content=\"RMoore\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RMoore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657\"},\"author\":{\"name\":\"RMoore\",\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/#\\\/schema\\\/person\\\/e2261897cb15c2610b283200b210f79c\"},\"headline\":\"The Art of War\\\/Medicine\",\"datePublished\":\"2013-12-31T18:24:17+00:00\",\"dateModified\":\"2014-02-19T20:06:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657\"},\"wordCount\":707,\"commentCount\":0,\"articleSection\":[\"Medical Practice\",\"Prevention\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657\",\"url\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657\",\"name\":\"The Art of War\\\/Medicine - PHC Primary Care Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/#website\"},\"datePublished\":\"2013-12-31T18:24:17+00:00\",\"dateModified\":\"2014-02-19T20:06:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/#\\\/schema\\\/person\\\/e2261897cb15c2610b283200b210f79c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/phcprimarycare.org\\\/?p=657\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/?p=657#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/phcprimarycare.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Art of War\\\/Medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/#website\",\"url\":\"https:\\\/\\\/phcprimarycare.org\\\/\",\"name\":\"PHC Primary Care Blog\",\"description\":\"Partnership HealthPlan of California\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/phcprimarycare.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/phcprimarycare.org\\\/#\\\/schema\\\/person\\\/e2261897cb15c2610b283200b210f79c\",\"name\":\"RMoore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f0ba7e9946a1ad594a0070ed009f75ea00cb69b3f7271511fd722377966e54bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f0ba7e9946a1ad594a0070ed009f75ea00cb69b3f7271511fd722377966e54bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f0ba7e9946a1ad594a0070ed009f75ea00cb69b3f7271511fd722377966e54bd?s=96&d=mm&r=g\",\"caption\":\"RMoore\"},\"url\":\"https:\\\/\\\/phcprimarycare.org\\\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Art of War\/Medicine - PHC Primary Care Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/phcprimarycare.org\/?p=657","og_locale":"en_US","og_type":"article","og_title":"The Art of War\/Medicine - PHC Primary Care Blog","og_description":"Recently updated guidelines for treatment of high cholesterol levels have just been released by the American College of Cardiology \u2013 American Heart Association Task Force on Practice Guidelines. They\u00a0represent a change","og_url":"https:\/\/phcprimarycare.org\/?p=657","og_site_name":"PHC Primary Care Blog","article_published_time":"2013-12-31T18:24:17+00:00","article_modified_time":"2014-02-19T20:06:42+00:00","author":"RMoore","twitter_misc":{"Written by":"RMoore","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/phcprimarycare.org\/?p=657#article","isPartOf":{"@id":"https:\/\/phcprimarycare.org\/?p=657"},"author":{"name":"RMoore","@id":"https:\/\/phcprimarycare.org\/#\/schema\/person\/e2261897cb15c2610b283200b210f79c"},"headline":"The Art of War\/Medicine","datePublished":"2013-12-31T18:24:17+00:00","dateModified":"2014-02-19T20:06:42+00:00","mainEntityOfPage":{"@id":"https:\/\/phcprimarycare.org\/?p=657"},"wordCount":707,"commentCount":0,"articleSection":["Medical Practice","Prevention"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/phcprimarycare.org\/?p=657","url":"https:\/\/phcprimarycare.org\/?p=657","name":"The Art of War\/Medicine - PHC Primary Care Blog","isPartOf":{"@id":"https:\/\/phcprimarycare.org\/#website"},"datePublished":"2013-12-31T18:24:17+00:00","dateModified":"2014-02-19T20:06:42+00:00","author":{"@id":"https:\/\/phcprimarycare.org\/#\/schema\/person\/e2261897cb15c2610b283200b210f79c"},"breadcrumb":{"@id":"https:\/\/phcprimarycare.org\/?p=657#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/phcprimarycare.org\/?p=657"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/phcprimarycare.org\/?p=657#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/phcprimarycare.org\/"},{"@type":"ListItem","position":2,"name":"The Art of War\/Medicine"}]},{"@type":"WebSite","@id":"https:\/\/phcprimarycare.org\/#website","url":"https:\/\/phcprimarycare.org\/","name":"PHC Primary Care Blog","description":"Partnership HealthPlan of California","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/phcprimarycare.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/phcprimarycare.org\/#\/schema\/person\/e2261897cb15c2610b283200b210f79c","name":"RMoore","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f0ba7e9946a1ad594a0070ed009f75ea00cb69b3f7271511fd722377966e54bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f0ba7e9946a1ad594a0070ed009f75ea00cb69b3f7271511fd722377966e54bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f0ba7e9946a1ad594a0070ed009f75ea00cb69b3f7271511fd722377966e54bd?s=96&d=mm&r=g","caption":"RMoore"},"url":"https:\/\/phcprimarycare.org\/?author=2"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p293xY-aB","_links":{"self":[{"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=\/wp\/v2\/posts\/657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=657"}],"version-history":[{"count":12,"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=\/wp\/v2\/posts\/657\/revisions"}],"predecessor-version":[{"id":745,"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=\/wp\/v2\/posts\/657\/revisions\/745"}],"wp:attachment":[{"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/phcprimarycare.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}